Business
Novavax COVID-19 vaccine production set back due to supply shortages – ABC News
Novavax pushes back the timeline for hitting its production target of 150 million COVID-19 vaccine doses per month due to supply shortages, dealing another blow…
Novavax Inc has pushed back the timeline for hitting its production target of 150 million COVID-19 vaccine doses per month until the third quarter due to supply shortages, dealing another blow to the federal government’s rollout plans.
Key points:
- Novavax is one of three companies the federal government struck a deal with to distribute COVID-19 vaccines in Australia
- It will need to be imported to Australia because of a lack of capable vaccine manufacturers
- The company has faced difficulties sourcing…
Continue Reading
-
Business22 hours ago3 ASX 200 shares set to dominate the next decade
-
Business8 hours ago3 of the best ASX shares to buy with $5,000
-
Business24 hours agoForget CBA, Macquarie is tipping a 40% return for this ASX financial stock
-
Noosa News21 hours agoTwo young girls charged following a string of assaults and robberies in Queensland’s south east